Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.48 |
| ▸ | PRNP | P04156 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4736696 | 0.84 | MAPT (0.51) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| SCHEMBL7362843 | 0.83 | HTR1B (0.64) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| SCHEMBL12370653 | 0.83 | MAPT (0.50) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7360142 | 0.81 | HTR1B (0.62) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| SCHEMBL14393504 | 0.81 | GAA (0.61) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| SCHEMBL12370651 | 0.80 | MAPT (0.48) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| SCHEMBL7362748 | 0.79 | RAB9A (0.51) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| SCHEMBL12745123 | 0.78 | MAPT (0.58) | MAPTMAPK1RAB9AL3MBTL1SMN1; SMN2 | |
| SCHEMBL23515218 | 0.76 | HTR1B (0.57) | MAPTMAPK1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL29625729 | 0.76 | HTR1B (0.57) | MAPTMAPK1RAB9ASMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6307090-B1 | OXALYL ENDCAPPED; CONTAINING A BIVALENT RADICAL OF PHOSPHOTYROSINE OR A PHOSPHOTYROSINE MIMETIC | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-10-23 | — | — | US | disclosed |
| EP-0846127-A1 | ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY | Novartis AG (CH) | 1998-06-10 | — | — | EP | disclosed |
| WO-1997008193-A1 | ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY | NOVARTIS AG (CH) | 1997-03-06 | — | — | WO | disclosed |